Please join us for the next meeting of the Madison, Wisconsin CMTA Branch (via Zoom) on Thursday, March 4 at 6:00 p.m. Central Time when we will welcome a special guest speaker Dr. John Svaren who very involved in CMTA’s STAR research program and chairs the CMTA’s Scientific Advisory Board. We are lucky to have him right here locally at our very own UW Madison Waisman Center Research Institute.  Dr. Svaren will be giving us a “boots on the ground” update on the progress being made in the research of CMT.  This will be an informative and interactive meeting with time for Q/A. Dr. Svaren is an amazing individual, and this is a meeting you will not want to miss. All are welcome – we love meeting new people!

To receive the Zoom link needed to join this meeting, please RSVP to Branch Leader Deb Weber: weberd@firstweber.com.

More on Dr. Svaren: John is a professor in the Department of Comparative Biosciences at the University of Wisconsin, and he serves as director of the Cellular and Molecular Neuroscience core at the UW Waisman Center, where his laboratory is located. Since 2000, he has focused his research program on the genetic basis of peripheral myelination and the disruptions found in peripheral neuropathies such as CMT. He began working with the CMTA to lead one arm of the collaborative STAR project, which investigated PMP22 regulation to develop assays for drug screening for CMT1A. As the scope of CMTA’s mission expanded, he became a board member of the CMTA and chair of its scientific advisory board. In this capacity, John works with scientists and neurologists in the development and implementation of a multi-front strategy to develop new therapies for the common forms of CMT.